CivicKnodeCivicKnowA project of CivicKnode
Sign in

HB 255

Did not advance
Add to calendar

Maryland Internship Opportunities Program - Creation and Income Tax Credit

Sponsor: Samuel I. Rosenberg (District 41)Committee: AppropriationsSubject: Higher EducationStatus: Hearing 2/01 at 1:00 p.m. (Appropriations) (as of Nov 15, 2022)

What this bill does

Official synopsis

Establishing the Maryland Internship Opportunities Program to provide students with internship opportunities with humanities-based businesses; allowing certain employers a credit, up to $4,200 for each eligible intern, against the State income tax for employing certain eligible interns subject to certain limitations; requiring the Maryland Department of Labor to adopt regulations specifying criteria and procedures for the application for and approval of tax credit certificates; etc.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (11)

MGA witness list
FAV 11Favorable
PositionWitnessOrganizationTestimony
FAVBrinlee, KirstenBaltimore Collegetown NetworkOral + Written (PDF)
FAVCoates-Young, LatishaBaltimore HomecomingWritten (PDF)
FAVSutton, JenniferDelegate Rosenberg's OfficeOral + Written (PDF)
FAVFry, DonaldGreater Baltimore CommitteeWritten (PDF)
FAVVoytek, MaddyMD Chamber of CommerceWritten (PDF)
FAVWeinschenck, AnnieMD Technology Internship ProgramPosition only
FAVFidler, SaraMaryland Independent College and University AssociationWritten (PDF)
FAVSchmittle, HollyPlanit Advertising, Inc.Written (PDF)
FAVHogan, PatricklobbyistUniversity System of MarylandWritten (PDF)
FAVDelegate Rosenberg, Delegate RosenberglegislatorIndividualOral
FAVMir, IlsaIndividualOral + Written (PDF)

Organizations on record

Registered lobbyists who testified

FAVHogan, PatrickUniversity System of MarylandRegistered for: ALS Association, The; Adobe Inc.; Amgen, Inc.; Annie E. Casey Foundation, Inc., The; AstraZeneca Pharmaceuticals, LP; Capital One